Lawrence Otto Klein - Insider Trading & Ownership

Entity
Individual
Location
C/O Crispr Therapeutics Ag, 610 Main Street 7 Th Floor, Cambridge, Massachusetts
Summary
The estimated net worth of Lawrence Otto Klein is at least $1.69 M dollars as of June 8, 2023. Lawrence Otto Klein is the CBO & COO of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $1.67 M. Lawrence Otto Klein is the Director of Jasper Therapeutics, Inc. and owns shares of Jasper Therapeutics, Inc. (JSPR) stock worth about $15.9 K.
All Insider Reports
All Insider Reports

Ownership of Lawrence Otto Klein

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRSP CRISPR Therapeutics AG Cbo & Coo $1.67 M Aug 16, 2022
JSPR, JSPRW Jasper Therapeutics, Inc. Director $15.9 K Jun 7, 2023
DYN Dyne Therapeutics, Inc. Director Jul 5, 2022

Insider Transactions Reported by Lawrence Otto Klein:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership